Newsmakers: Delcath Systems, ImmunoCellular Therapeutics, Oncolytics Biotech, Concert Pharmaceuticals, CTI BioPharma Print E-mail
Wednesday, 17 September 2014 14:28

Stocks rose and bonds held steady, as investors were reassured by the vertical-align:baseline; prospect of low interest rates for a while longer.

The Federal Reserve said Wednesday that it would keep short-term interest rates near zero for a "considerable time." However, the U.S. central bank in its latest policy statement also confirmed that it would end its bond-buying program next month and offered new details on what mechanism it plans to blog comments powered by Disqus
 
conversions // _pa.revenue = "19.99"; // OPTIONAL: attach dynamic purchase values to conversions // _pa.productId = "myProductId"; // OPTIONAL: Include product ID for use with dynamic ads var pa = document.createElement('script'); pa.type = 'text/javascript'; pa.async = true; pa.src = ('https:' == document.location.protocol ? 'https:' : 'http:') + "//tag.perfectaudience.com/serve/542d8983a391ee1c86000113.js"; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(pa, s); })(); BMR:1